Baseline data for the two study cohorts. Results are given as mean (SEM)
| Study subjects | Age (years) | Height (cm) | Weight (kg) | BMD spine (g/cm2) | u-CartiLaps (ng/mmol) | s-CrossLaps (pmol/l) | |
|---|---|---|---|---|---|---|---|
| *p<0.001. | |||||||
| Alendronate | 63 | 52.8 (2.1)* | 163.7 (5.2) | 61.6 (6.8) | 0.93 (0.09) | 178.7 (110.6) | 4423.0 (1527.1) |
| Ibandronate | 119 | 64.7 (5.3)* | 163.0 (5.4) | 68.1 (11.8) | 0.86 (0.13) | 218.0 (231.0) | 4607.6 (1691.2) |